关注
Dr Roshan Kamal Topno
Dr Roshan Kamal Topno
Epidemiology
没有经过验证的电子邮件地址
标题
引用次数
引用次数
年份
Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus
R Kumar, M Nayak, GC Sahoo, K Pandey, MC Sarkar, Y Ansari, VNR Das, ...
Journal of Infection and Chemotherapy 25 (5), 325-329, 2019
1742019
Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey
MV Murhekar, P Kamaraj, MS Kumar, SA Khan, RR Allam, P Barde, ...
The Lancet Global health 7 (8), e1065-e1073, 2019
1152019
Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in Bihar, India
RK Topno, VNR Das, A Ranjan, K Pandey, D Singh, N Kumar, ...
The American journal of tropical medicine and hygiene 83 (3), 502, 2010
1112010
Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India
VP Singh, A Ranjan, RK Topno, RB Verma, NA Siddique, VN Ravidas, ...
The American journal of tropical medicine and hygiene 82 (1), 9, 2010
1022010
National noncommunicable disease monitoring survey (NNMS) in India: estimating risk factor prevalence in adult population
P Mathur, V Kulothungan, S Leburu, A Krishnan, HK Chaturvedi, ...
PloS one 16 (3), e0246712, 2021
722021
Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T …
MR Dikhit, A Kumar, S Das, B Dehury, AK Rout, F Jamal, GC Sahoo, ...
Frontiers in immunology 8, 1763, 2017
692017
Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes
VNR Das, NA Siddiqui, RB Verma, RK Topno, D Singh, S Das, A Ranjan, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 105 (11 …, 2011
672011
Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis
R Kumar, K Pandey, GC Sahoo, S Das, VNR Das, RK Topno, P Das
Materials Science and Engineering: C 75, 1465-1471, 2017
582017
Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development
MR Dikhit, MY Ansari, R Mansuri, BR Sahoo, B Dehury, A Amit, RK Topno, ...
Infection, Genetics and Evolution 45, 187-197, 2016
572016
Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
VN Das, K Pandey, N Verma, CS Lal, S Bimal, RK Topno, D Singh, ...
The American journal of tropical medicine and hygiene 80 (3), 336-338, 2009
532009
Development of PLGA–PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis
R Kumar, GC Sahoo, K Pandey, VNR Das, RK Topno, MY Ansari, S Rana, ...
Materials Science and Engineering: C 59, 748-753, 2016
512016
Kala-azar elimination in a highly-endemic district of Bihar, India: A success story
V Kumar, R Mandal, S Das, S Kesari, DS Dinesh, K Pandey, VR Das, ...
PLoS neglected tropical diseases 14 (5), e0008254, 2020
412020
Possible factors causing acute encephalitis syndrome outbreak in Bihar, India
DS Dinesh, K Pandey, VNR Das, RK Topno, S Kesari, V Kumar, A Ranjan, ...
Int J Curr Microbiol App Sci 2 (12), 531-538, 2013
392013
Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India
K Pandey, VNR Das, D Singh, S Das, CS Lal, N Verma, S Bimal, ...
Journal of clinical microbiology 50 (4), 1478-1479, 2012
382012
The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India
R Sarnoff, J Desai, P Desjeux, A Mittal, R Topno, NA Siddiqui, A Pandey, ...
Tropical Medicine & International Health 15, 42-49, 2010
372010
Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India
P Das, S Samuels, P Desjeux, A Mittal, R Topno, NA Siddiqui, D Sur, ...
Tropical Medicine & International Health 15, 4-11, 2010
362010
Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS)
A Krishnan, P Mathur, V Kulothungan, HR Salve, S Leburu, R Amarchand, ...
BMC health services research 21 (1), 1-12, 2021
352021
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive …
VNR Das, NA Siddiqui, K Pandey, VP Singh, RK Topno, D Singh, ...
Therapeutics and Clinical Risk Management 5, 117, 2009
312009
Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey
MS Kumar, P Kamaraj, SA Khan, RR Allam, PV Barde, B Dwibedi, ...
The Lancet Microbe 2 (1), e41-e47, 2021
282021
Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers
VNR Das, S Bimal, NA Siddiqui, A Kumar, K Pandey, SK Sinha, RK Topno, ...
PLoS neglected tropical diseases 14 (6), e0008272, 2020
272020
系统目前无法执行此操作,请稍后再试。
文章 1–20